Sundar, S; Chakravarty, J (Jan 2013). "Leishmaniasis: an update of current pharmacotherapy.". Expert opinion on pharmacotherapy14 (1): 53–63. doi:10.1517/14656566.2013.755515. பப்மெட்:23256501.
Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.". The Journal of antimicrobial chemotherapy67 (11): 2576–97. doi:10.1093/jac/dks275. பப்மெட்:22833634.
Lozano, R (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.". Lancet380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. பப்மெட்:23245604.
Ejazi, SA; Ali, N (Jan 2013). "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.". Expert review of anti-infective therapy11 (1): 79–98. doi:10.1586/eri.12.148. பப்மெட்:23428104.
Sundar, S; Chakravarty, J (Jan 2013). "Leishmaniasis: an update of current pharmacotherapy.". Expert opinion on pharmacotherapy14 (1): 53–63. doi:10.1517/14656566.2013.755515. பப்மெட்:23256501.
Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.". The Journal of antimicrobial chemotherapy67 (11): 2576–97. doi:10.1093/jac/dks275. பப்மெட்:22833634.
Lozano, R (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.". Lancet380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. பப்மெட்:23245604.
Ejazi, SA; Ali, N (Jan 2013). "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.". Expert review of anti-infective therapy11 (1): 79–98. doi:10.1586/eri.12.148. பப்மெட்:23428104.